Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 11 . 21 . 2023 Press release Galderma reports record net sales of over 3 B USD for the first nine months of 2023 with strong growth momentum across all product categories 10 . 26 . 2023 Press release Galderma phase III data published in The New England Journal of Medicine: full Olympia 2 trial results demonstrate nemolizumab’s rapid onset of action in patients with prurigo nodularis 10 . 23 . 2023 News story Providing optimal care for optimal results with Cetaphil 10 . 13 . 2023 Press release Galderma unveils bold ambition in neuromodulation at Liquid Live event 10 . 11 . 2023 Press release Galderma @ EADV 2023: phase III trials demonstrate nemolizumab’s efficacy and rapid onset of action in atopic dermatitis and prurigo nodularis 10 . 4 . 2023 News story EADV 2023: Galderma's scientific presentations 10 . 4 . 2023 Press release EADV 2023: Galderma to present new data showcasing its continued leadership in dermatology 10 . 3 . 2023 News story “A product for any type of skin”: celebrating Cetaphil’s range and reliability 10 . 2 . 2023 News story Alastin Skincare: Galderma announces launch in the UK and direct distribution and expansion in Canada 10 . 2 . 2023 Press release Galderma announces progress with RelabotulinumtoxinA regulatory submissions 9 . 14 . 2023 Press release Galderma launches advanced new serum with ALASTIN Skincare® - C-RADICAL Defense Antioxidant Serum 9 . 14 . 2023 News story Galderma’s World Eczema Week: driving change for the community Pagination Previous page Previous Page Next page Next Page